2026 is set to be a game-changing year for Life Sciences regulation in Europe.
Join our webinar for a forward-looking update on the most important regulatory developments shaping the industry. We’ll break down the European Pharma Package, highlight what’s coming next for the MedTech sector due to the amendments to the MDR/IVDR. You’ll also get a concise overview of Health Technology Assessment (HTA) and its growing impact on market access. Stay ahead of the curve and get ready for what’s next in Life Sciences Regulatory – because 2026 will be anything but business as usual.
Online
in Präsenz
